Graham Capital Management, L.P. Dice Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $675,398 - $837,701	-25,927 Reduced 22.29%	90,414 $2.59 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $2.1 Million - $4.48 Million	106,170 Added 1043.85%	116,341 $3.63 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $152,259 - $230,373	10,171 New	10,171 $206,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.